
Here are the latest updates on Byju’s crisis as its second auditor, BDO, resigns over financial concerns:
- BDO Resigns: BDO (MSKA & Associates) has resigned as Byju’s auditor, citing financial and governance concerns.
- Second Auditor Exit: This resignation follows Deloitte’s exit last year due to similar issues with Byju’s financial reporting.
- Key Issues Highlighted: BDO pointed out significant delays in financial reporting and insufficient management support.
- Outstanding Payments: Concerns were raised about Byju’s ability to recover approximately Rs 1,400 crore from a Dubai-based entity.
- Legal Challenges: Byju’s is facing multiple legal battles, including ongoing litigation and liquidation proceedings initiated by creditors.
- Management Criticism: BDO’s resignation letter mentioned a lack of cooperation from Byju’s management, including failure to supply crucial information.
- Financial Discrepancies: The resignation comes amid Byju’s delayed submission of its FY22 financial results, which led to Deloitte’s earlier resignation.
- Company Valuation: Once valued at $22 billion, Byju’s is now grappling with severe financial and operational challenges.
- Audit Tenure: BDO was appointed as Byju’s auditor in August 2023, filling the vacancy left by Deloitte.
- Future Implications: The resignation of two auditors in quick succession raises serious questions about Byju’s financial health and governance practices.
-
Indian Bank Deposit Rates 2025: Are You Missing Out on 7.65% Returns?
Indian Bank’s FD rates, up to 7.65% p.a.! Explore IND SECURE, IND GREEN, and tax-saving schemes with high
-
Axis Bank Personal Loan: Offers Up to ₹40 Lakh at 9.99% Interest!
Axis Bank Personal Loan: Borrow ₹50,000-₹40 lakh at 9.99% p.a. with flexible 12-84 month tenures. Enjoy quick approvals,
-
Airtel Axis Credit Card: Is It the Best Choice for Utility Bills and Food Delivery?
Axis Airtel Credit Card: Unlock 25% cashback on Airtel services, 10% on utilities, Swiggy, Zomato, plus lounge access!
-
Review of Penny Stock Welcure Drugs & Pharmaceuticals Limited
Welcure Drugs & Pharmaceuticals, a volatile penny stock with high return potential. Explore its financials, business pivot, pros,